Precision medicine has revolutionized the field of healthcare by tailoring treatments to individual patients based on their unique genetic makeup and disease characteristics. This review paper explores the pivotal role of next-generation sequencing (NGS) and tumor markers in advancing precision medicine, with a particular focus on early cancer detection and personalized treatment. We discuss key milestones in the development of precision medicine, highlighting the transformative impact it has had on patient care. Next-generation sequencing (NGS)Next-generation sequencing (NGS) technology has emerged as a powerful tool for comprehensive genomic profiling, enabling the identification of genetic alterations that drive cancer progression. Simultaneously, tumor markers have become invaluable in the early detection and monitoring of cancer, providing clinicians with essential diagnostic and prognostic information. Integrating NGS and tumor markers facilitates a holistic understanding of the disease, aiding in early diagnosis and treatment decision-making. Personalized medicine offers numerous benefits, including improved treatment outcomes, reduced adverse effects, and enhanced patient quality of life. Genomic profilingGenomic profiling plays a pivotal role in personalized cancer treatment, allowing for the identification of targetable genetic mutations and the selection of targeted therapies tailored to the individual patient’s genetic makeup and tumor characteristics. However, several challenges hinder the widespread implementation of personalized medicine. Ethical considerations, including patient consent for using genomic data in treatment, are paramount. Moreover, addressing privacy and security concerns surrounding the storage and sharing of genomic information is crucial to maintaining patient trust. One promising avenue for advancing personalized cancer treatment is the integration of whole-genome sequencing with tumor marker analysis. This combination provides a comprehensive view of a patient’s genetic landscape, enabling the development of more effective and precise treatment strategies. We explore the potential benefits and challenges associated with this integrated approach. The integration of whole-genome sequencing and tumor marker analysis shows promise in refining personalized treatment strategies. Despite challenges, this approach holds great potential for improving cancer care. This review provides insights into precision medicine’s current status, genomic profiling’s pivotal role, and vital ethical and practical considerations for successful implementation.